Cvs Pharmacy # 02449 Durable Medical Equipment & Medical Supplies Location: 11240 Perry Highway, Wexford, Pennsylvania 15090 Phone: (724) 935-7890 |
Giant Eagle Pharmacy #0043 Community/Retail Pharmacy Location: 155 Towne Centre Dr, Wexford, Pennsylvania 15090 Phone: (724) 934-0201 |
Rite Aid Pharmacy 07825 Durable Medical Equipment & Medical Supplies Location: 201 Devine Dr, Wexford, Pennsylvania 15090 Phone: (724) 935-1880 |
Ccs Medical Durable Medical Equipment & Medical Supplies Location: 10475 Perry Hwy, Wexford, Pennsylvania 15090 Phone: (800) 599-7521 |
Allegheny Health Network Home Medic Durable Medical Equipment & Medical Supplies Location: 12311 Perry Hwy, Wexford, Pennsylvania 15090 Phone: (800) 272-3233 |
Walgreens #10282 Durable Medical Equipment & Medical Supplies Location: 30 Pine Creek Rd, Wexford, Pennsylvania 15090 Phone: (412) 366-2456 |
Continuum Llc Durable Medical Equipment & Medical Supplies Location: 2400 Corporate Dr, Wexford, Pennsylvania 15090 Phone: (800) 344-1550 |
Pediatric And Adult Vision Care Medicare Supplier Location: 110 Vip Dr, Wexford, Pennsylvania 15090 Phone: (724) 935-9999 |
Boston Orthotics & Prosthetics Prosthetic/Orthotic Supplier Location: 171 Wexford Bayne Rd, Wexford, Pennsylvania 15090 Phone: (412) 837-3825 |
Eye Physicians Optical Llc Durable Medical Equipment & Medical Supplies Location: 7000 Stonewood Dr, Wexford, Pennsylvania 15090 Phone: (724) 940-4001 |
Eyecare Specialties Of Pennsylvania Medicare Supplier Location: 110 Vip Dr, Wexford, Pennsylvania 15090 Phone: (724) 935-9999 |
Visionworks Eyewear Supplier (Equipment, not the service) Location: 12311 Perry Hwy, Wexford, Pennsylvania 15090 Phone: (724) 933-2400 |
News Archive
The Cancer Center at Sanford-Burnham Medical Research Institute (Sanford-Burnham) has received a five-year core grant renewal from the National Cancer Institute (NCI).
Amidst the sound and fury of concern over various aspects of President Obama's health care reform proposal, observers too often lose sight of the core fundamental principles on which the President is correct, according to the Employers Council on Flexible Compensation.
The U.S. Food and Drug Administration today approved Jevtana (cabazitaxel), a chemotherapy drug used in combination with the steroid prednisone to treat men with prostate cancer. Jevtana is the first treatment for advanced, hormone-refractory, prostate cancer that has worsened during or after treatment with docetaxel, a commonly used drug for advanced prostate cancer.
The New York Times on Thursday examined a study that found asymptomatic HIV-positive people who delayed antiretroviral treatment until their disease reached an advanced stage faced higher mortality rates than those who initiated treatment earlier.
› Verified 8 days ago